clinical trial · NCT06451666
Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia
CSPC Ouyi Pharmaceutical Co., Ltd.·phase3·not yet recruiting·n = 330
PresbyopiaPilocarpine HCl Ophthalmic SolutionVehicle
brief summary
A study to evaluate the efficacy, safety, and pharmacokinetics of pilocarpine HCl ophthalmic solution when administered bilaterally, once daily for 30 days in participants with presbyopia.
started
Jun 30, 2024
primary completion
Nov 30, 2025
completion
Dec 30, 2025
last updated
Jul 3, 2024
official title
A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Pilocarpine HCl in Participants With Presbyopia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol